EEG
ALDX icon

E.E. Geduld’s Aldeyra Therapeutics ALDX Stock Holding History

E.E. Geduld’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,000
Closed -$105K – 247
2014
Q2 		$105K Buy
+16,000
New +$107K 0.07% 224

Other funds holding ALDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

E.E. Geduld's ALDX Position: Q3 2014 in Review

E.E. Geduld sold out of Aldeyra Therapeutics (ALDX) in Q3 2014, closing a stake of 16,000 shares — an estimated $105K sold.

E.E. Geduld first reported a position in ALDX in Q2 2014 and held it in 1 quarter. The position peaked at $105K in Q2 2014. 7 funds tracked by Wall St. Rank hold ALDX as of Q3 2014.

  • E.E. Geduld reported no remaining Aldeyra Therapeutics position as of Q3 2014 after selling out during the quarter.
  • E.E. Geduld sold 16,000 Aldeyra Therapeutics shares in Q3 2014, an estimated $105K.
  • E.E. Geduld first reported a position in Aldeyra Therapeutics in Q2 2014 and held it in 1 quarter.
  • E.E. Geduld's Aldeyra Therapeutics position peaked at $105K in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2014.

Based on E.E. Geduld's 13F filing for Q3 2014, filed 30 Oct 2014.